nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Clozapine—HRH3—narcolepsy	0.00642	0.0987	CrCbGaD
Prochlorperazine—Cyamemazine—HTR2A—narcolepsy	0.00411	0.0633	CrCbGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00297	0.00317	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HCRTR1—narcolepsy	0.00296	0.00317	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HCRTR2—narcolepsy	0.00296	0.00317	CbGpPWpGaD
Prochlorperazine—Zuclopenthixol—HTR2A—narcolepsy	0.00295	0.0454	CrCbGaD
Prochlorperazine—Nefazodone—HTR2A—narcolepsy	0.00293	0.0451	CrCbGaD
Prochlorperazine—HRH1—GPCR ligand binding—HCRTR1—narcolepsy	0.00291	0.00311	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HCRTR2—narcolepsy	0.00291	0.00311	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00286	0.00306	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00286	0.00306	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—P2RY11—narcolepsy	0.00286	0.00306	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00285	0.00305	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—PENK—narcolepsy	0.00284	0.00303	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—P2RY11—narcolepsy	0.00281	0.00301	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00281	0.003	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0028	0.00299	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00278	0.00297	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00277	0.00296	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—HCRT—narcolepsy	0.00276	0.00295	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00275	0.00294	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00275	0.00294	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00274	0.00294	CbGpPWpGaD
Prochlorperazine—Aripiprazole—HTR2A—narcolepsy	0.00272	0.0419	CrCbGaD
Prochlorperazine—Trazodone—HTR2A—narcolepsy	0.00271	0.0417	CrCbGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00269	0.00288	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00269	0.00288	CbGpPWpGaD
Prochlorperazine—DRD2—G alpha (i) signalling events—HRH3—narcolepsy	0.00267	0.00286	CbGpPWpGaD
Prochlorperazine—Acepromazine—HTR2A—narcolepsy	0.00264	0.0407	CrCbGaD
Prochlorperazine—HRH1—G alpha (q) signalling events—TAC1—narcolepsy	0.00261	0.00279	CbGpPWpGaD
Prochlorperazine—HRH1—G alpha (q) signalling events—NPS—narcolepsy	0.00261	0.00279	CbGpPWpGaD
Prochlorperazine—Thioproperazine—HTR2A—narcolepsy	0.00258	0.0397	CrCbGaD
Prochlorperazine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00258	0.00276	CbGpPWpGaD
Prochlorperazine—Thiothixene—HTR2A—narcolepsy	0.00254	0.0391	CrCbGaD
Prochlorperazine—Pipotiazine—HTR2A—narcolepsy	0.00254	0.0391	CrCbGaD
Prochlorperazine—DRD2—Circadian rythm related genes—NPS—narcolepsy	0.00251	0.00268	CbGpPWpGaD
Prochlorperazine—Mesoridazine—HTR2A—narcolepsy	0.00251	0.0386	CrCbGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00248	0.00265	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—PENK—narcolepsy	0.00246	0.00263	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00243	0.0026	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HCRT—narcolepsy	0.00243	0.0026	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00242	0.00259	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—TRH—narcolepsy	0.00241	0.00258	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00241	0.00257	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0024	0.00256	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HCRT—narcolepsy	0.00239	0.00256	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00238	0.00254	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00235	0.00252	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00234	0.0025	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00233	0.0025	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00233	0.0025	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0023	0.00246	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0023	0.00246	CbGpPWpGaD
Prochlorperazine—Mianserin—HTR2A—narcolepsy	0.0022	0.0338	CrCbGaD
Prochlorperazine—Fluphenazine—HTR2A—narcolepsy	0.0022	0.0338	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00219	0.00234	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00219	0.00234	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—PENK—narcolepsy	0.00217	0.00232	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—PENK—narcolepsy	0.00213	0.00228	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00212	0.00227	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—P2RY11—narcolepsy	0.00211	0.00226	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—HRH3—narcolepsy	0.00211	0.00226	CbGpPWpGaD
Prochlorperazine—Propiomazine—HTR2A—narcolepsy	0.00211	0.0325	CrCbGaD
Prochlorperazine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.0021	0.00224	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—TRH—narcolepsy	0.00209	0.00224	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00209	0.00223	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00205	0.00219	CbGpPWpGaD
Prochlorperazine—Clomipramine—HTR2A—narcolepsy	0.00201	0.0309	CrCbGaD
Prochlorperazine—Chlorprothixene—HTR2A—narcolepsy	0.002	0.0308	CrCbGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00199	0.00213	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00199	0.00213	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HCRTR2—narcolepsy	0.00199	0.00213	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HCRTR1—narcolepsy	0.00199	0.00213	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—P2RY11—narcolepsy	0.00192	0.00205	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.0019	0.00203	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.0019	0.00203	CbGpPWpGaD
Prochlorperazine—Thioridazine—HTR2A—narcolepsy	0.00189	0.0291	CrCbGaD
Prochlorperazine—DRD2—GPCR ligand binding—TRH—narcolepsy	0.00184	0.00197	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—P2RY11—narcolepsy	0.00183	0.00196	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—HRH3—narcolepsy	0.00183	0.00196	CbGpPWpGaD
Prochlorperazine—HTR2C—G alpha (q) signalling events—HTR2A—narcolepsy	0.00181	0.00194	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—TRH—narcolepsy	0.00181	0.00194	CbGpPWpGaD
Prochlorperazine—Methotrimeprazine—HTR2A—narcolepsy	0.00181	0.0278	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HCRT—narcolepsy	0.0018	0.00192	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00179	0.00191	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00178	0.00191	CbGpPWpGaD
Prochlorperazine—Promethazine—HTR2A—narcolepsy	0.00178	0.0274	CrCbGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00176	0.00188	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00176	0.00188	CbGpPWpGaD
Prochlorperazine—Trifluoperazine—HTR2A—narcolepsy	0.00176	0.027	CrCbGaD
Prochlorperazine—DRD3—GPCR ligand binding—TAC1—narcolepsy	0.00175	0.00187	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—NPS—narcolepsy	0.00175	0.00187	CbGpPWpGaD
Prochlorperazine—Loxapine—HTR2A—narcolepsy	0.00174	0.0268	CrCbGaD
Prochlorperazine—Perphenazine—HTR2A—narcolepsy	0.00174	0.0267	CrCbGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00173	0.00185	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00173	0.00185	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HCRTR2—narcolepsy	0.00172	0.00184	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HCRTR1—narcolepsy	0.00172	0.00184	CbGpPWpGaD
Prochlorperazine—Quetiapine—HTR2A—narcolepsy	0.0017	0.0262	CrCbGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0017	0.00182	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0017	0.00182	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00168	0.00179	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00168	0.00179	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—P2RY11—narcolepsy	0.00166	0.00178	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00164	0.00176	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00164	0.00176	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HCRT—narcolepsy	0.00163	0.00175	CbGpPWpGaD
Prochlorperazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00162	0.00173	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00162	0.00173	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00162	0.00173	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—P2RY11—narcolepsy	0.00162	0.00173	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HRH3—narcolepsy	0.00162	0.00173	CbGpPWpGaD
Prochlorperazine—Desipramine—HTR2A—narcolepsy	0.00162	0.0249	CrCbGaD
Prochlorperazine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00162	0.00173	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—PENK—narcolepsy	0.0016	0.00171	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—P2RY11—narcolepsy	0.00159	0.0017	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HRH3—narcolepsy	0.00159	0.0017	CbGpPWpGaD
Prochlorperazine—HRH1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00157	0.00168	CbGpPWpGaD
Prochlorperazine—Promazine—HTR2A—narcolepsy	0.00157	0.0241	CrCbGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00156	0.00167	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00156	0.00167	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HCRT—narcolepsy	0.00156	0.00167	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HCRTR2—narcolepsy	0.00152	0.00163	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HCRTR1—narcolepsy	0.00152	0.00163	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—NPS—narcolepsy	0.00152	0.00162	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—TAC1—narcolepsy	0.00152	0.00162	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HCRTR1—narcolepsy	0.00149	0.0016	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HCRTR2—narcolepsy	0.00149	0.0016	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00147	0.00157	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00147	0.00157	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—P2RY11—narcolepsy	0.00147	0.00157	CbGpPWpGaD
Prochlorperazine—Clozapine—HTR2A—narcolepsy	0.00146	0.0225	CrCbGaD
Prochlorperazine—DRD3—Signaling by GPCR—PENK—narcolepsy	0.00146	0.00156	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—P2RY11—narcolepsy	0.00144	0.00154	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00142	0.00152	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HCRT—narcolepsy	0.00142	0.00151	CbGpPWpGaD
Prochlorperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0014	0.0015	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0014	0.0015	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—PENK—narcolepsy	0.00139	0.00149	CbGpPWpGaD
Prochlorperazine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00138	0.00148	CbGpPWpGaD
Prochlorperazine—Chlorpromazine—HTR2A—narcolepsy	0.00138	0.0212	CrCbGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HCRT—narcolepsy	0.00138	0.00147	CbGpPWpGaD
Prochlorperazine—Imipramine—HTR2A—narcolepsy	0.00137	0.0211	CrCbGaD
Prochlorperazine—DRD3—GPCR downstream signaling—TRH—narcolepsy	0.00136	0.00146	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HCRT—narcolepsy	0.00135	0.00144	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—TAC1—narcolepsy	0.00134	0.00143	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—NPS—narcolepsy	0.00134	0.00143	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00133	0.00142	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—NPS—narcolepsy	0.00132	0.00141	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—TAC1—narcolepsy	0.00132	0.00141	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00129	0.00138	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00129	0.00138	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—PENK—narcolepsy	0.00126	0.00135	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HCRT—narcolepsy	0.00125	0.00134	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—TRH—narcolepsy	0.00124	0.00132	CbGpPWpGaD
Prochlorperazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00124	0.00132	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HCRT—narcolepsy	0.00123	0.00131	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—PENK—narcolepsy	0.00123	0.00131	CbGpPWpGaD
Prochlorperazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00121	0.0013	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00121	0.00129	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—PENK—narcolepsy	0.0012	0.00129	CbGpPWpGaD
Prochlorperazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0012	0.00128	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HRH3—narcolepsy	0.00119	0.00128	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00119	0.00128	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00118	0.00127	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—TRH—narcolepsy	0.00118	0.00126	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HCRTR2—narcolepsy	0.00117	0.00126	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HCRTR1—narcolepsy	0.00117	0.00126	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—P2RY11—narcolepsy	0.00113	0.00121	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—PENK—narcolepsy	0.00111	0.00119	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—PENK—narcolepsy	0.00109	0.00117	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HRH3—narcolepsy	0.00108	0.00116	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00108	0.00115	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—TRH—narcolepsy	0.00107	0.00115	CbGpPWpGaD
Prochlorperazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00106	0.00113	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR ligand binding—HTR2A—narcolepsy	0.00105	0.00113	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—TRH—narcolepsy	0.00104	0.00111	CbGpPWpGaD
Prochlorperazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00104	0.00111	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HRH3—narcolepsy	0.00104	0.00111	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—TRH—narcolepsy	0.00102	0.00109	CbGpPWpGaD
Prochlorperazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00102	0.00109	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HCRTR2—narcolepsy	0.00102	0.00109	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HCRTR1—narcolepsy	0.00102	0.00109	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00101	0.00108	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—NPS—narcolepsy	0.00099	0.00106	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—TAC1—narcolepsy	0.00099	0.00106	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—P2RY11—narcolepsy	0.000983	0.00105	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HCRT—narcolepsy	0.000964	0.00103	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—TRH—narcolepsy	0.000947	0.00101	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HRH3—narcolepsy	0.000941	0.00101	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—TRH—narcolepsy	0.00093	0.000994	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000915	0.000978	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HRH3—narcolepsy	0.000914	0.000978	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR ligand binding—HTR2A—narcolepsy	0.000914	0.000977	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—NPS—narcolepsy	0.000899	0.000961	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—TAC1—narcolepsy	0.000899	0.000961	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HCRTR2—narcolepsy	0.000899	0.000961	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HCRTR1—narcolepsy	0.000899	0.000961	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HRH3—narcolepsy	0.000898	0.00096	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000883	0.000945	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HCRTR2—narcolepsy	0.000882	0.000944	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HCRTR1—narcolepsy	0.000882	0.000944	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000868	0.000928	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000868	0.000928	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—P2RY11—narcolepsy	0.000868	0.000928	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—PENK—narcolepsy	0.00086	0.000919	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—TAC1—narcolepsy	0.000858	0.000918	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—NPS—narcolepsy	0.000858	0.000918	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—P2RY11—narcolepsy	0.000852	0.000911	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.000838	0.000897	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HCRT—narcolepsy	0.000836	0.000894	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HRH3—narcolepsy	0.00083	0.000888	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HRH3—narcolepsy	0.000815	0.000872	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR ligand binding—HTR2A—narcolepsy	0.000806	0.000862	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000802	0.000858	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR ligand binding—HTR2A—narcolepsy	0.000792	0.000847	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—TAC1—narcolepsy	0.000779	0.000834	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—NPS—narcolepsy	0.000779	0.000834	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000779	0.000833	CbGpPWpGaD
Prochlorperazine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000768	0.000821	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—TAC1—narcolepsy	0.000757	0.00081	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—NPS—narcolepsy	0.000757	0.00081	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—PENK—narcolepsy	0.000745	0.000797	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—TAC1—narcolepsy	0.000744	0.000795	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—NPS—narcolepsy	0.000744	0.000795	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HCRT—narcolepsy	0.000738	0.000789	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000732	0.000783	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000732	0.000783	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TRH—narcolepsy	0.000731	0.000782	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HCRT—narcolepsy	0.000725	0.000775	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000713	0.000762	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CHKB—narcolepsy	0.000712	0.000762	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—TAC1—narcolepsy	0.000688	0.000736	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—NPS—narcolepsy	0.000688	0.000736	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—TAC1—narcolepsy	0.000675	0.000722	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—NPS—narcolepsy	0.000675	0.000722	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000665	0.000711	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000665	0.000711	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—PENK—narcolepsy	0.000658	0.000703	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—PENK—narcolepsy	0.000646	0.000691	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HRH3—narcolepsy	0.000641	0.000685	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000635	0.00068	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TRH—narcolepsy	0.000634	0.000678	CbGpPWpGaD
Prochlorperazine—DRD3—GPCR downstream signaling—HTR2A—narcolepsy	0.000596	0.000637	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TRH—narcolepsy	0.000559	0.000598	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HRH3—narcolepsy	0.000556	0.000594	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TRH—narcolepsy	0.000549	0.000587	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling by GPCR—HTR2A—narcolepsy	0.000541	0.000578	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00054	0.000578	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—TAC1—narcolepsy	0.000531	0.000568	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—NPS—narcolepsy	0.000531	0.000568	CbGpPWpGaD
Prochlorperazine—HTR2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000516	0.000552	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HRH3—narcolepsy	0.00049	0.000524	CbGpPWpGaD
Prochlorperazine—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000484	0.000518	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HRH3—narcolepsy	0.000481	0.000515	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000474	0.000507	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling by GPCR—HTR2A—narcolepsy	0.000469	0.000501	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CHKB—narcolepsy	0.000466	0.000498	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—NPS—narcolepsy	0.00046	0.000492	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—TAC1—narcolepsy	0.00046	0.000492	CbGpPWpGaD
Prochlorperazine—DRD2—GPCR downstream signaling—HTR2A—narcolepsy	0.000456	0.000487	CbGpPWpGaD
Prochlorperazine—HRH1—GPCR downstream signaling—HTR2A—narcolepsy	0.000447	0.000479	CbGpPWpGaD
Prochlorperazine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.00044	0.000471	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling by GPCR—HTR2A—narcolepsy	0.000414	0.000443	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—NPS—narcolepsy	0.000406	0.000435	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—TAC1—narcolepsy	0.000406	0.000435	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling by GPCR—HTR2A—narcolepsy	0.000406	0.000435	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.0004	0.000428	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—TAC1—narcolepsy	0.000399	0.000427	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—NPS—narcolepsy	0.000399	0.000427	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000393	0.00042	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000393	0.00042	CbGpPWpGaD
Prochlorperazine—DRD3—Signaling Pathways—HTR2A—narcolepsy	0.000319	0.000342	CbGpPWpGaD
Prochlorperazine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000316	0.000338	CbGpPWpGaD
Prochlorperazine—HTR2C—Signaling Pathways—HTR2A—narcolepsy	0.000277	0.000296	CbGpPWpGaD
Prochlorperazine—DRD2—Signaling Pathways—HTR2A—narcolepsy	0.000244	0.000261	CbGpPWpGaD
Prochlorperazine—HRH1—Signaling Pathways—HTR2A—narcolepsy	0.00024	0.000257	CbGpPWpGaD
Prochlorperazine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000236	0.000253	CbGpPWpGaD
